Dosing Study of Replagal in Patients With Fabry Disease - Contacts and Locations

Home

Dosing Study of Replagal in Patients With Fabry Disease

This study is ongoing, but not recruiting participants.

Study NCT00068107. Last updated on September 15, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00068107

Locations


United States, Maryland
	National Institutes of Health Clinical Center, 9000 Rockville Pike
	Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)